Robert F. Booth - 28 Sep 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Robert F. Booth
Issuer symbol
SMMT
Transactions as of
28 Sep 2022
Net transactions value
$0
Form type
4
Filing time
03 Oct 2022, 16:50:56 UTC
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +200,000 200,000 28 Sep 2022 Common Stock 200,000 $1.21 Direct F1, F3
transaction SMMT Stock Option (right to buy) Award +6,250 +3.1% 206,250 28 Sep 2022 Common Stock 6,250 $1.21 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on September 28, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on September 28, 2023.
F2 The option was granted on September 28, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022.
F3 Not applicable.